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1. Introduction
 
Dual diagnosis, or the co-existence of mental health and substance misuse problems, 
is not a new phenomenon. Psychiatric services have had long-standing challenges 
in helping patients with mental health problems who drink to excess. Similarly, drug 
and alcohol services have always worked with a number of clients with substance 
misuse problems who also suffer from a variety of mental health problems, including 
depression, anxiety states and psychosis. What has changed over the past two decades 
is a dramatic increase in the range and availability of street drugs (EMCDD, 2007). 
So dual diagnosis is nothing new, but it has become far more common both in the 
community and within prisons. 
By its nature, responsibility for dual diagnosis overlaps a number of the health and 
social care services provided in prisons, including primary and secondary mental 
health services, drug treatment services, chaplaincy and peer support groups (such 
as the Listeners). Prisons vary in the way in which the functions of mental health and 
substance misuse interventions are divided between these respective departments. 
Therefore, these guidelines are intended to be used as a framework that can be 
adapted by individual establishments to provide co-ordinated services to this highly 
disadvantaged client group. 
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2. Defining dual diagnosis
 
The term ‘dual diagnosis’ covers a wide range of problems that have both mental 
health and substance misuse in common. Dual diagnosis can consequently mean 
different things to different service providers, but it can be summarised within four 
principal definitions: 
A primary mental health problem that provokes the use of substances
(As may be the case with someone suffering from schizophrenia who finds that 

heroin reduces some of his symptoms.) 

Substance misuse and/or withdrawal leading to psychiatric symptoms 

or illnesses
 
(Emergence of depression post-detoxification – insomnia and low mood; also 

the emergence of a psychiatric disorder to which the individual was vulnerable 

pre-substance misuse.) 

A psychiatric problem that is worsened by substance misuse
(For example, a person with heightened anxiety of danger from others who uses 
cannabis to relax, but finds that the cannabis can increase their paranoia, leading to 
increased alienation.) 
Substance misuse and mental health problems that do not appear to be 

related to one another
 
(For example, someone who has an ongoing anxiety problem that is neither 

lessened nor worsened by drug or alcohol use.)
 
These guidelines have been written to assist all services within prisons (primary care, 
mental health, drug treatment) to manage patients who have a mental health and a 
substance misuse problem. 
Compared with people who have either a mental health or a substance misuse 
problem, clients with a dual diagnosis are more likely to have had difficulties with 
education, employment, accommodation, sexual abuse, personal relationships, general 
health and neurological damage (Banerjee, Clancy and Crome, 2002; Social Exclusion 
Unit, 2002). 
In accordance with the mental health in prisons strategy (Department of Health, 2001), 
patients with a severe mental health problem must always have a full risk assessment 
and be treated within the Care Programme Approach (CPA). 
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3. Who has responsibility for the care 
of dual diagnosis? 
Overall care 
Everyone working for the Prison Service has a duty of care towards every prisoner. 
This duty includes any prisoner with a co-existent mental health and substance misuse 
problem. 
Primary care 
Since 2004, responsibility for the commissioning of healthcare services within public 
prisons has transferred to the National Health Service. NHS primary care trusts 
commission healthcare services to ensure that responsibility and accountability for both 
mental and physical health are clearly defined. 
Mental health 
Facilitation and co-ordination of the delivery of primary mental health interventions 
(i.e. interventions that are planned for the management of non-severe mental health 
problems) is the responsibility of the primary healthcare manager. 
Physical health 
The responsibility to manage the delivery of general medical and nursing services is also 
that of the healthcare manager. The Mental Health Policy Implementation Guide states: 
‘Assessment of the physical health needs of these people [with mental 
health problems] lies entirely within the remit of primary care, and as 
described above, the physical health consequences are significant e.g. 
a third of people with dual diagnosis will be sero-positive for either HIV, 
Hepatitis B or Hepatitis C.’ 
(Department of Health, 2002) 
There are strong links between physical well-being and mental health. It is important 
that there are firm connections between the mental health care providers and the 
physical health care providers. 
Substance misuse 
The overall responsibility to facilitate the delivery lies with the healthcare manager. 
In many prisons the responsibility for the direct delivery of clinical substance misuse 
interventions within the prison (i.e. management of withdrawal from alcohol and 
all drugs of dependence, opioid maintenance prescribing and prescribing to protect 
against relapse into problem drinking or drug use) lies with the clinical substance 
misuse manager or senior practitioner. 
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Responsibility for the delivery of CARATs (Counselling, Assessment, Referral, Advice and 
Throughcare) services resides with the CARATs service manager. These systems are now 
coming together in a singular multi-disciplinary treatment team, as a key element of 
the integrated drug treatment system (IDTS) (HMPS, 2006). 
Medicines management 
The overall responsibility for ensuring care and control of medicines, including safe and 
effective prescribing, lies with the chief pharmacist. In many prisons this may be the 
lead pharmacist of the commissioning PCT. However, where medicines management 
services are commissioned it is important that prison healthcare staff, including 
prescribers who may be commissioned on a sessional basis, have access to expert 
pharmaceutical advice. In view of the high prevalence of mental health and substance 
misuse problems within the prison population, it is desirable that this pharmaceutical 
advice should come from specialist mental health pharmacists. It is important that 
pharmaceutical services provide more than just a supply service in order to ensure 
safe and effective use of medicines. Commissioners should refer to the Healthcare 
Commission 2007 review Talking about medicines: The management of medicines 
in trusts providing mental health services. 
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4. Mental health – legal framework 
Care Programme Approach 
From October 2008, there has been one single CPA process (replacing the old 
‘enhanced’ and ‘standard’ CPA system). Throughout this document, all references 
to CPA will relate to this new single process. 
The Department of Health (DH) has identified, in particular, mental health service users: 
•	 who have parenting responsibilities; 
•	 who have significant caring responsibilities; 
•	 with a dual diagnosis (substance misuse); 
•	 with a history of violence or self harm; and 
•	 who are in unsettled accommodation. 
In relation to the CPA, DH states that: 
‘The default position for individuals from these groups would normally be 
under (new) CPA unless a thorough assessment of need and risk shows 
otherwise.’ 
(DH, 2008) 
Responsibility for access by this client group to CPA rests with the head of mental 
healthcare services within each prison. A care co-ordinator, who is usually but not 
always a member of the mental health service team, has lead responsibility for delivery 
of CPA. 
Mental Health Act 2007 
Individuals suffering from “any disorder or disability of the mind” come within the 
scope of the Mental Health Act 2007. This definition includes sexual deviancy. 
This change to the Mental Health Act, and the publication of the guidelines Personality 
disorder: No longer a diagnosis of exclusion (NIMHE, 2003), suggest that personality 
disorder qualifies for treatment via mental health services. 
At present, a significant majority of people with personality disorder remain 
undiagnosed. People who have a personality disorder may also have another serious 
mental health problem, such as a psychotic or major affective disorder. Clinical 
presentation can be complicated further by substance misuse. Unfortunately, when 
personality disorder is overlooked, there is an increased risk of treatment failure, 
leading to disengagement with services. 
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Multi-Agency Public Protection Arrangements 
Multi-Agency Public Protection Arrangements (MAPPA) support the assessment and 
management of the most serious sexual and violent offenders. 
The aim of MAPPA is to ensure that a risk management plan that is drawn up for the 
most serious offenders benefits from the information, skills and resources provided by 
the individual agencies being co-ordinated through MAPPA. 
MAPPA were introduced in 2001, and bring together the police, probation and prison 
services into what is known as the MAPPA Responsible Authority. 
Other agencies are under a duty to co-operate with the Responsible Authority, 
including social care, health, housing and education services. 
There are four key features within MAPPA: 
1. Identifying offenders to be supervised under MAPPA 
This is generally determined by the offender’s offence and sentence, but assessed risk is 
also factored in. There are three formal categories: 
•	 Category One: Registered sex offenders; 
•	 Category Two: Violent or other sex offenders; and 
•	 Category Three: Other offenders. 
2. Sharing of information about offenders 
MAPPA promote information sharing between all the agencies, resulting in more 
effective supervision and better public protection. For example: 
•	 Police will share with offender managers information that they have 
gathered about an offender’s behaviour from surveillance or intelligence 
gathering. 
•	 Local authorities will help to find offenders suitable accommodation where 
they can be effectively managed. 
Victims’ needs are required to be represented in MAPPA, so that additional measures 
can be taken to manage risks posed to known victims. 
3. Assessing the risks posed by offenders 
Most MAPPA offenders do not present a risk of serious harm to the public: the MAPPA 
enable resources and attention to be focused on those who present the highest risks. 
4. Managing the risk posed by individual offenders 
MAPPA offenders are managed at one of three levels. 
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Level One: involves normal agency management 
Generally offenders managed at this level will be assessed as presenting a low or 
medium risk of serious harm to others. 
Level Two: often called local inter-risk agency management 
This includes most offenders assessed as being at high or very high risk of 
causing harm. 
Level Three: known as Multi-Agency Public Protection Panels (MAPPPs) 
MAPPPs are appropriate for those offenders who pose the higest risk of causing 
serious harm or whose management is so problematic that multi-agency co-operation 
and oversight at a senior level is required, with the authority to commit exceptional 
resources.
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5. Current practice within the 
Prison Service 
Most prisons across the country practise what is known as a parallel approach to 
dual diagnosis. A parallel approach involves the provision of care by more than one 
treatment service at the same time. 
The most common example of this would be a prisoner who is under the care of 
the primary healthcare team for the management of his mental health problem, and 
receiving help from the drug treatment services team to address his substance misuse 
problem. An alternative version of this model would feature the involvement of a 
secondary (specialist) mental health team alongside the substance misuse services. 
An important variation on this approach involves three separate teams working with 
a prisoner: the mental health team providing the patient with mental health care, the 
drug treatment services providing a range of substance misuse interventions, and the 
primary healthcare team providing other clinical services. 
The parallel approach is a recognised and accepted response to dual diagnosis. Its 
principal advantage lies in the fact that a client receives specialist help for each of the 
different aspects of his or her problem. The main disadvantage of this system lies in the 
need for sharing important information between two or sometimes three treatment 
teams, and the potential that this holds for miscommunication. It can also be perceived 
as providing fragmented care to the recipient. For it to meet the complex needs of 
this group of people in prison, the parallel approach must therefore be developed to 
become as fully integrated as possible. 
Relative merits of parallel and integrated approaches 
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Integrated approach 
The introduction of the integrated drug treatment system in prisons (HMPS, 2006), 
which brings healthcare and CARATs teams far more closely together, provides a basis 
for integrated care of dual diagnosis, involving joint care planning, case reviews and 
co-ordinated through-care. 
A number of larger prisons have now established specialist dual diagnosis services, 
which combine some of the most relevant functions of mental health and substance 
misuse with strong links to primary healthcare, wider supportive prison services and 
community mental health teams. This system is described in more detail in Section 6. 
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6. What works?
 
There is a relatively small body of evidence for what is effective in the treatment of dual 
diagnosis in the UK and elsewhere. Recommended approaches tend to be less precise 
than in other areas of treatment. Instead, broader principles of good practice are more 
appropriate to guide planners and practitioners. These principles are as follows. 
Integrated treatment 
A co-ordinated approach from all professionals involved both within the prison and 
from community services. This often involves a biopsychosocial model of working that 
addresses medical, psychological and social needs. 
DH (2002) and the Royal College of Psychiatrists (2002) recommend the integrated 
approach. 
Staged interventions 
The mental well-being of a patient with a dual diagnosis is dependent on the 
harmonisation of interventions. Rapid changes in environment and/or pharmacology 
can threaten this balance, worsening a mental disorder. 
Social support interventions 
Both mental health problems and drug dependence are conditions that have 
been found to respond favourably to cohesive social support (e.g. Gumley, 1999; 
Smith, Meyers & Miller, 2001). This approach has to take account of stigma and 
the related fear in the social network, which impedes reintegration for individuals 
with dual diagnosis. 
Longer-term perspective 
Clients with a serious mental health and a substance misuse problem are at increased 
risk of becoming isolated from carers and families, becoming homeless, acquiring HIV, 
engaging in violent behaviour and committing suicide. This poor outlook suggests that 
treatment programmes should feature realistic goals and be gradually paced. 
Interventions matched to level of need 
Clients with a mild to moderate mental health need are best served within a primary 
care setting – access to primary care in both prisons and the community is generally 
easy, and suitably trained practitioners (Hughes, 2006) have the ability to manage less 
severe mental health problems. 
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7. Recommended approaches
 
Two treatment approaches are described below. Option A is a specialist team model; 
Option B is a model that utilises existing provision. 
Option A: Specialist dual diagnosis team 
In view of the large number of prisoners with both mental health and substance misuse 
problems, some prisons have established specialist dual diagnosis teams. In the main, 
these teams comprise professionals with a background in psychiatry, psychology, social 
care and substance misuse. The service offered by these teams may be described within 
four categories: 
1.	 Assessment. The dual diagnosis team takes referrals from other service 
providers within the prison, and sees the client with a view to evaluating 
his or her care needs across a wide number of domains, including mental 
health, cognitive ability, social functioning (pre and post release), skills for 
living and substance use. These factors also need to be assessed in terms 
of functioning prior to entry into prison, as containment can limit the 
expression of certain difficulties that emerge on transfer or release. 
2.	 Consultation. Where the dual diagnosis team judges that the client’s range 
of problems does not necessitate their direct involvement, they make a 
recommendation to the referring department (usually the integrated drug 
treatment system (IDTS) team) on future case management. As it represents 
a resource of expertise, the dual diagnosis team remains available for future 
supervision and consultation. 
3.	 Individual case work. In instances where the dual diagnosis team decides 
that the client needs specialist help, it provides this service, including care 
co-ordination, as part of the CPA. 
4.	 Education and advice. The dual diagnosis team provides training to 
primary healthcare and substance misuse teams in order to increase their 
knowledge base and thereby enable them to provide services to clients with 
more complex needs. Again, this work includes ongoing supervision of the 
staff who have received training. 
One substantial risk with this approach is that responsibility for dual diagnosis can be 
mistakenly regarded as sitting with just a few overburdened practitioners. Very clear 
pathways of care, and specific skills and knowledge training for mainstream staff 
(primary mental health and substance misuse), are necessary in order to neutralise 
this risk. The use of both shared care protocols and regular case review meetings 
is beneficial. 
A difficulty with a fragmented model of care is that progress can often be undetected 
by one service. Thus, one service may see little or no change in the targets/goals they 
have set, but another service may see progress in a different set of targets. Also, 
decisions made by one service can be detrimental to another service. For example, 
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a practitioner working with an individual with avoidance of emotions (common in 
personality disorder and substance misuse) may be working with them on increasing 
their willingness to experience painful emotions. If the individual then presents at 
another service highly distressed and appearing at risk, they may receive medication 
or psychological interventions that remove their exposure to painful emotions, thus 
undermining the therapeutic model. Integrated case notes are therefore invaluable for 
ensuring that risk plans and care plans are shared. 
A model of care may be established in accordance with Section 8: ‘Good practice’. 
Option B: Utilising and integrating existing services 
This is the more practical approach for the majority of prisons. 
In this model, primary healthcare, mental health and substance misuse teams meet in 
order to decide how they can manage the mental health and substance misuse needs 
of prisoners who have a dual diagnosis. 
The system they design should be written up in the form of a clear and straightforward 
protocol. This protocol should include statements on each of the following: 
1. What is dual diagnosis? 
Establishments may wish to adopt the four definitions from page 2, or generate their 
own definitions. 
2. What is the most practical way of providing care to patients/ 
clients from each of these four categories? 
These care pathways will make up the majority of the protocol. They should address 
methods of assessment, referral, joint care planning, care reviews, and arrangements 
for release from prison. Outside agencies benefit from being invited in to help with 
pre-release planning at an early stage, and to begin the process of engagement with 
the individual. 
3. Confidentiality 
What information may be shared between treatment teams? What information 
may be shared with outside agencies (see Appendix A: Guidance on consent 
and confidentiality). This is a vital issue and needs clear guidelines. Frequently, 
outside agencies are given insufficient information due to unhelpful boundaries 
on confidentiality. 
4. Who co-ordinates care? 
How is a CPA Care Co-ordinator chosen? How does their role link with the other IDTS 
and community services? How is self-harm and suicide risk managed across teams? 
(ACCT: Assessment, Care in Custody and Teamwork, PSI 18/2005). 
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5. How will training and supervision be provided? 
Can reciprocal training be arranged, with drug treatment team members providing 
substance misuse advice and training to healthcare and mental health staff members, 
and mental health specialists offering advice and training to substance misuse and 
general health practitioners? Can a local dual diagnosis specialist be brought in to 
provide joint training and supervision? 
6. What will be the model of care? 
This will be explored in Section 8: ‘Good practice’. 
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8. Good practice
 
The most important elements of good practice in the care of patients with dual 
diagnosis are early identification of need, continuity, specialist skills and flexibility. 
Early identification of need 
On admission for clinical management of dependence, the substance misuse team 
should be alert to any history of mental health problems (or current mental health 
issues) which might worsen if detoxification is undertaken. These conditions include 
psychotic disorders (including schizophrenia and drug-induced psychosis), bipolar 
affective disorder, clinical depression, behavioural problems or any symptoms that 
a patient states have worsened when he/she has stopped taking drugs or alcohol 
in the past. 
Mental health assessment should be readily accessible as part of the reception function, 
i.e. a reception nurse in primary care is able to pass patients with a positive mental 
health screen to a mental health trained practitioner immediately as part of the initial 
assessment. This way prisoners will be allocated to the right location from the outset, 
to receive the immediate care identified by the practitioner. 
Mental health assessment is a complex process. Accuracy is of high importance to 
ensure that the prisoner gets the most appropriate treatment as soon as possible. 
Assessors should have training and expertise in physical health, mental health and 
substance misuse. With regard to mental health they would need expertise across 
Axis I (mood disorders, psychotic disorders, anxiety disorders) and Axis II (personality 
disorders) as well as the interactions between substance use, physical health and 
cognitive ability. Assessment should lead onto formulation, which is the process by 
which an understanding is reached of the ways in which individual factors combine 
to create problems that a detailed care plan should address. 
As part of any dual diagnosis service, practitioners and commissioners should optimise 
access to psychological therapies for offenders with mental health problems (NHS, 
2009). 
Safe prescribing 
It is vital that systems are in place for reviewing prescribing and that these systems 
ensure that interventions can be made speedily and advice given to prescribers from 
specialist mental health trained pharmacists. 
Opiate or benzodiazepine dependence 
Opiate-dependent patients arriving in prison custody with serious mental health 
problems should be stabilised – rather than detoxified – for a minimum period of two 
weeks. During this time the mental health team should be asked to assess the patient. 
A plan of care should be made jointly, between the substance misuse team and the 
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mental health team, taking into account patient choice and the views of other agencies 
including community services (see Section 9: ‘Continuity of care’). 
As a standard intervention for all other opiate-dependent offenders arriving in prison 
(including individuals with mild to moderate mental health problems), five days of 
stabilisation should be prescribed (DH, 2006), during which time ongoing monitoring 
and assessment will inform the planning of care. 
In some cases of co-existent serious mental health problems and opiate dependence, 
long-term maintenance may be indicated (RCPsych, 2002). If a reduction regime 
is preferred, this should be at a pace that the patient can manage, agreed by all, 
and closely monitored by both substance misuse and mental health teams. Any 
deterioration in the patient’s mental state should result in a review of treatment, with 
consideration of returning to, and maintaining, levels of medication at which the 
patient was stable; or provision of additional appropriate mental health interventions. 
Benzodiazepine withdrawal may cause the emergence of symptoms of psychosis; 
patients with a previous history of thought disorder may have a greater vulnerability 
to this effect. In the event of such an episode, substance misuse and mental health 
teams should review jointly the patient’s benzodiazepine (diazepam) reduction regime 
and monitor the effect of this adjustment regularly. A period of stabilisation may be 
required before any further reduction in diazepam is considered. Anxiety and self-
harm can emerge as a result of withdrawal of benzodiazepines (Prison drug treatment 
and self-harm, PSI46/2005); stabilisation followed by a slower reduction may again 
be indicated. Chronic benzodiazepine use can also cause ongoing difficulties with 
cognitive processing and memory, which can last beyond completion of a reduction 
programme. It is therefore important to assess the ongoing cognitive capacity of 
individuals after detoxification. Cognitive capacity is relevant to both psychological 
treatment planning and social and occupational treatment planning in the future. 
Stimulant dependence 
Withdrawal from stimulants can cause a brief but sometimes profound depression. 
This may take anything from one week to several months to resolve as the central 
nervous system adapts physiologically to the changed chemical environment. During 
this time a prisoner may be at enhanced risk of suicide or self-harm. If their low mood 
gives cause for concern, a risk assessment should be carried out in accordance with the 
prison risk management system (ACCT: Assessment, Care in Custody and Teamwork, 
PSI 18/2005). 
It is also important to note that stimulant use is common among those who suffer from 
chronic boredom or a high stimulation threshold which is common in individuals with 
a personality disorder, in particular borderline or antisocial personality disorder. Thus, 
identification of an underlying personality disorder will be important for treatment 
planning (NICE, 2009a; 2009b). 
The management and treatment of self-harm and suicide are complex. A comprehensive 
assessment and formulation are critical to making plans for appropriate risk management
and treatment. 
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Additionally, stimulant use can cause a psychotic episode (‘amphetamine psychosis’). 
Cessation of stimulant use, sleep and nourishment will usually reverse this problem. 
One of the criteria for borderline personality disorder is ‘transient psychotic symptoms 
when under periods of stress’. Stimulants increase stress, so psychotic symptoms need 
to be carefully assessed as they can be part of amphetamine psychosis, a psychotic 
disorder or a personality disorder. 
As with other substances, the cessation of consumption can lead to a reappearance 
of a concealed serious mental health problem. Engagement in the integrated drug 
treatment system psychosocial interventions across the first 28 days of custody 
(HMPS, 2006) can help to identify emerging problems of this kind. 
Some clients in prison value supportive individual and group interventions throughout 
the early weeks of stimulant withdrawal. Complementary interventions such as guided 
relaxation and acupuncture have also been regarded as helpful in stabilising mood 
during this phase. Integrated Drug Treatment System: the First 28 Days: Psychosocial 
Support (NOMS, 2006) describes interventions that are suited for the management of 
problematic drug use and the psychological impact of withdrawal. These interventions 
include ones specifically for primary stimulant users. 
Placing individuals with dual diagnosis into group treatments needs to be considered 
carefully. Many people with significant mental health difficulties have had highly 
traumatic childhoods and recent histories. They are also likely to have some difficulties 
with socialising. These issues are particularly relevant for those with a personality 
disorder. Thus, careful and complete assessment and psychological formulation will 
be important for making decisions about group or individual treatments. It does not 
need to be a psychologist who makes this decision, but must be a team of people with 
psychological assessment and formulation skills. 
Relapse to severe stimulant dependence on release from prison can raise very 
substantial health, social and re-offending risks. For this reason, continuity of care 
is a vital element of any stimulant intervention – including ensuring that community-
based services are involved in CPA and release planning, and have an opportunity 
wherever possible to meet and engage with prisoners well before their release. 
Continuity of care should include a package of care tailored to the individual which 
includes substance misuse, health, mental health, and robust social care. 
Child protection and welfare 
The ‘Hidden Harm’ report by the Advisory Council on the Misuse of Drugs (ACMD, 
2003) stated that parental problem drug use can and does cause serious harm to 
children at every age, and that reducing harm to children from parental problem 
drug use should become a main objective of policy and practice. It concluded that 
effective treatment of the parent can have major benefits for the child, and services 
and clinicians need to work together to protect and improve the health and well-being 
of affected children. 
The UK guidelines for drug treatment (DH, 2007) state that assessment of drug-
misusing parents should take into consideration: 
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•	 the effect of drug misuse on functioning, for example, intoxication or 
agitation; 
•	 the effect of drug-seeking behaviour, for example, leaving children 
unsupervised, contact with unsuitable characters; 
•	 the impact of the parent’s physical and mental health on parenting; 
•	 how drug use is funded, for example, sex working, diversion of family income; 
•	 emotional availability to children; 
•	 effects on family routines, for example, getting children to school on time; 
•	 other support networks, for example, family support; 
•	 ability to access professional support; and 
•	 storage of illicit drugs, prescribed medication and drug-using paraphernalia. 
With consent, information should be gathered from other professionals. 
Ryan (2008) recommends the following approach by practitioners:
•	 document whether the patient has childcare responsibilities; 
•	 document information given to the patient when take-home doses are 
given; 
•	 use integrated care to the fullest extent with patients who are parents; 
•	 involve other professionals at the earliest stage if any concerns arise; and 
•	 follow Area Child Protection Committee or Local Safeguarding Children 
Board procedures. 
Limit settings 
In setting limits, it is very important that they are clear, achievable, fair, appropriate to 
the desired behaviour and consistently applied. There must also be room for flexibility 
and an awareness that these limits can change. 
As stated above, response to crossing of limits must be applied consistently, in order to 
avoid the risk escalation of problematic behaviour through intermittent reinforcement. 
Fazel and Danesh (2002) found that 65% of male and 42% of female prisoners had 
a personality disorder. In both groups, antisocial personality disorder was the most 
prevalent, but there were also high rates of borderline personality disorder. A statistical 
review of prisons found that: 
“… The most striking association between substance misuse and mental 
disorder was that between drug dependence before coming to prison and 
an assessment of personality disorder.” 
(Singleton, 1999) 
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Specialist skills 
Differing levels of skills and knowledge are required to work with people with a dual 
diagnosis. These vary from core competences, such as the capability to contribute 
to the delivery of some aspect of care for people with dual diagnosis, to specialist 
competences, which feature the ability to advise on the planning and co-ordination 
of care across different services for a wide complexity of need. These capabilities are 
set out in the dual diagnosis (Hughes, 2006) and personality disorder (NIMHE, 2003) 
capabilities frameworks. 
Flexibility 
The concept of dual diagnosis covers a very broad range of problems of varying 
intensity. It is important, therefore, that care should be planned on an individual basis, 
and should consider: 
•	 an individual’s readiness for change and engagement with services
 
(this can be improved by using motivational interviewing);
 
•	 any current substance misuse and associated risks (from sharing of injecting 

equipment, for instance);
 
•	 a client’s social network. This is particularly important in view of the high degree 
of isolation experienced by this patient group. Vulnerable adults in prison are 
often poor in social problem solving (Husband, 2008). Specific treatments in 
social problem solving have been developed; 
•	 meaningful daytime activity which is consistent with a person’s level of ability 
to engage and in line with positive longer-term goals, such as employment or 
continued education. Occupational therapy models are helpful here; 
•	 sound pharmacological management. This should accord with treatment that 
the patient has received in the community or (if recently transferred) from a 
local prison; 
•	 relationship needs: rebuilding relationships with partners and with children; and 
•	 cognitive capacity – Corrigan and Deutschle (2008) found very high rates of 

traumatic brain injury among those with a co-morbid substance dependence 

and personality disorder. This will influence ability to re-engage in the 

community and comply with treatment plans. 
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9. Continuity of care 
Continuity of care on release for clients with mild to 
moderate mental health problems 
This client group will not ordinarily be subject to the Care Programme Approach (CPA). 
They should have their care continued through two principal routes: 
•	 To ensure continuity of ongoing substance misuse needs, clients should – 
with their consent – be referred by the CARATs key worker/offender 
manager to their local drug/alcohol treatment service. For guidance on 
referral to the local Criminal Justice Integrated Teams (CJITs), please see 
Delivery of the Drug Interventions Programme in Prisons (NOMS, 2006). 
•	 To arrange continuity of mental and general healthcare, clients within 
this category should be referred to their GP in accordance with PSO 3050 
(HMPS, 2006). Where a prisoner who is receiving medical care that needs to 
continue after discharge does not have an external GP, it is important that 
healthcare staff help the prisoner to register with one prior to discharge. 
Continuity of care for individuals managed under the 
Care Programme Approach 
Clients whose care is planned and co-ordinated within the CPA, and who also have 
ongoing substance misuse needs, will require the care co-ordinator to take the lead 
for release planning, in direct contact with the community mental health team in the 
patient’s home area (DH, 2002). 
In the case of existing Drug Interventions Programme clients, CJITs and the local 
drug/alcohol services will need to be advised of forthcoming release but should not
be regarded as the lead agent for release planning in view of the pre-eminence of
enhanced mental health care needs. (For further advice for CJITs, see Drummond, 2008.)
Continuity of care for people with a dual diagnosis involves the forging of strong 
links with a patient’s home Community Mental Health Team and with the client’s 
Community Drug Team. The CPA will need to address needs across a wide range 
of provision: social care, housing, financial needs, reintegration into social networks, 
training, education and employment. 
It is important to be aware that in the community, the local mental health service has 
the main responsibility for co-ordinating the care of patients with a dual diagnosis 
involving the CPA: 
‘The statutory mental health sector has the responsibility for co-ordinating 
and providing a multi-agency approach to people with co-morbidity.’ 
Substance Misuse and Mental Health Co-Morbidity
(Dual Diagnosis) Health Advisory Service (2001) 
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Clear and detailed commissioning is required to ensure that all parties understand their 
responsibility towards people in prison with a dual diagnosis. 
Many establishments already have active working relationships with both local mental 
health and local drug service providers. Mental health trusts may provide secondary 
(i.e. specialist) psychiatric services to prison residents, or a local community drug service 
(which has an established working relationship with their local mental health trust) 
may also be providing drug treatment services in the prison. In these circumstances, 
arrangements for joint working may be relatively easy to achieve. 
Patients received into prison with an existing CPA will have that CPA continued 
(DH, 1999b). In these cases, the mental health team within the establishment will 
discuss with the community mental health team (CMHT) which service (i.e. the mental 
health team in prison or the CMHT) will provide a care co-ordinator. 
For patients who have no history of mental health treatment, but who demonstrate 
evidence of severe mental illness, the mental health team within his or her 
establishment will need to initiate the CPA when appropriate. Representation should be 
sought from the patient’s home mental health service (CMHT or child and adolescent 
mental health service (CAMHS)), and this community team will be involved in the 
planning of all subsequent care. 
While in prison, where there is less ready access to illicit drugs, a patient’s mental state 
may appear stable. A relatively low-stimulus environment such as prison can further 
mask existing mental health problems. The release care plan (or plan for transfer to 
a less secure prison) needs to take into account the previous history of substance 
misuse, as the patient may be liable to return to problematic drug and/or alcohol use 
on release. Planning should take account of any risk that may accompany a return to 
drug use, including reactivation of previous mental health problems. 
For guidance on the transfer of prisoners under the Mental Health Act, see Procedure 
for the transfer of prisoners to and from hospital under sections 47 and 48 of the 
Mental Health Act 1983 (www.dh.gov.uk/assetRoot/04/12/36/31/04123631.pdf). 
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10. Therapeutic issues 
Dependence 
Street drugs are usually psychoactive drugs that have effects on the mind. Rapid 
withdrawal from drugs of dependence can upset a patient’s mental equilibrium, 
heightening their risk of impulsive self-destructive behaviour. It is therefore 
recommended that a patient coming into custody with complex needs should 
be provided with clinical treatment to stabilise their withdrawal from opiate or 
benzodiazepine dependence. Consideration should be given at this early stage to the 
indication for opiate maintenance. DH (2006) recommends that anyone entering prison 
custody as a current stimulant user should be monitored for any sudden lowering in 
mood for the first three days of custody. Additionally, heavy stimulant use carries a risk 
of cardiac or cerebrovascular events. For this reason, monitoring should include blood 
pressure and neuro-observation as well as evaluation of mood. 
Details should be established of the planned care provided by the patient’s community 
mental health and dual diagnosis services prior to custody. The patient’s informed 
wishes and the advice of community providers should be taken into account when 
clinical substance misuse care is planned. If detoxification is the preferred action, the 
opinion of the Royal College of Psychiatrists is that a gradual reduction programme 
would be in the patient’s best interests (RCPsych, 2002). Simultaneous provision of full 
psychosocial support is a very important component of planned care (HMPS, 2006). 
Complications of withdrawal 
Some patients undergoing detoxification may show no signs of mental disorder until 
they reach an advanced stage in their detoxification programme. Timely and measured 
clinical intervention may help to contain these developing problems (see Section 8: 
‘Good practice‘). 
Depression can be a negative consequence of withdrawal – this may take some time to 
improve, and may require psychological and pharmacological interventions. 
Sleep disturbance is also common for a period after detoxification has completed and 
may only gradually improve. Insomnia can lead to increases in depression, anxiety 
and paranoia. 
Drug interactions 
Individuals who are prescribed psychotropic drugs for the management of a serious 
mental health problem can experience side-effects, some of which can be distressingly 
marked. Psychotropic medication can also interfere with other prescribed drugs, 
making both delivery of effective medical treatment and compliance with that 
treatment difficult to secure. Regular review of prescribed medication is important to 
guide clinicians to the best prescribed care for the patient. 
Page 21 
  
A Guide for the Management of Dual Diagnosis for Prisons
 
Compliance with planned treatment 
As previously mentioned, clients with complex needs are among the most social 
disadvantaged of our citizens. Many may have had negative past experiences of mental 
health services, drug treatment or social care, causing them to have a deep suspicion 
of the intentions of formal services. A sense of stigma may compound resistance to 
engage with treatment services. Sensitivity to these potential issues is a vital element 
in the construction of a care model. Engagement skills are an important means to 
enhance treatment compliance. 
Planned care 
As previously stated, clients with a serious mental health problem will need to be 
provided with care under the CPA. All care plans (whether under the CPA or not) 
should be negotiated with the client; this procedure may help to engender trust on 
the part of the client. 
Safer custody 
Dual diagnosis clients have a higher than average risk of suicide (DH, 2002). Care of 
clients should be planned with this vulnerability in mind. Risk assessments should be 
made in accordance with the at-risk procedures in place at the individual prison (i.e. the 
ACCT system). Close and continued communication between residential, health and 
substance misuse teams is essential to the best management of risk. To help reduce risk 
through an individualised care approach, it is important that representatives from as 
many disciplines as possible attend or contribute to ACCT case reviews. 
Histories of abuse 
In view of the high prevalence of sexual abuse in the personal histories of this client 
group, some therapeutic work around sexual abuse survival may be indicated. 
This work has to be carefully planned and conducted. Significant problems arise when 
interventions for childhood abuse are undertaken poorly or not fully completed. This 
leaves the individual with recurring memories and extremely painful thoughts which 
significantly increases the risk of either self-harm or relapse to damaging substance use. 
This work requires a trusting relationship with the therapist and a considerable length 
of time. If there is a possibility of prison transfer or discharge coming up, it is best to 
let this issue wait for a community team who can spend the time building a trusting 
relationship and working on the issues. It is also important to note that other forms of 
abuse are also highly damaging, in particular emotional abuse. 
Safer sex education may also be required. Clients who have been involved in sex work 
will also need training, education and employment work to provide a viable alternative 
to prostitution. 
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Physical health and well-being 
People with complex needs have limited opportunities to pay attention to their physical 
health. This client group can be helped greatly by a health check and management 
plan to address oral health, smoking, hazardous and harmful drinking, diet, anorexia 
or obesity. 
Individuals with mental health problems rarely come across the option to be tested for 
blood-borne viruses and to get treatment should they need it. While they are in prison 
this would be an ideal opportunity. Vaccination against both Hepatitis A and B should 
be offered. High-quality psychological care is essential for both pre-test and post-test 
counselling. 
Sexual health work is also important for this client group. This incorporates discussion 
of the risks associated with unprotected sexual activity, screening and access to 
treatment for sexually transmitted diseases. Again, skilled pre- and post-test counselling 
is required. Staff should make clients aware of how they can access condoms, dental 
dams and water-based lubricants within the prison. 
Harmful levels of drug use 
Substance misuse workers, by virtue of their training and professional experience, may 
regard low or moderate drug use as non-problematic. While this is true for the great 
majority of substance users, for people with serious mental health problems relatively 
small and infrequent consumption of drugs such as cannabis or amphetamine can have 
profoundly detrimental effects. 
Black and minority ethnic clients 
People of Afro-Caribbean ethnic origin are far more likely to be diagnosed as 
suffering from schizophrenia than are British White people. A black person is also 
more likely to be imprisoned in the UK than a white person. These facts combine to 
create a substantial need for services that can address the needs of this particularly 
disadvantaged group (HM Prison Service PSO 2800; Race Relations (Amendment) 
Act 2000). 
Access to prison drug services by black and minority ethnic (BME) prisoners is often very 
limited. Clinical teams should therefore monitor the utilisation of their service by this 
particularly disadvantaged group. 
Ongoing links with local community organisations should be developed to help make 
services more approachable. Areas that could be addressed to help BME patients 
include: 
•	 active BME staff recruitment (Race Relations (Amendment) Act 2000); 
•	 active BME prisoner recruitment for Prisoner Advisory Drug Services (PADS); 
•	 staff training programmes; 
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•	 the formulation and display of an anti-discriminatory policy in alliance with 
prison race relation teams (HM Prison Service PSO 2800); 
•	 compilation of a directory of BME community services including all faith 
groups; 
•	 links with interpreter services; 
•	 culturally relevant health promotion subject matter and materials; 
•	 particular regard to confidentiality issues; and 
•	 establishment of specialist stimulant (i.e. crack) treatment teams. 
Further guidance on the successful engagement of BME drug users and the equitable 
delivery of services to people with diverse needs in prison can be found in Making 
Equality Real (NOMS, 2008). 
Securing help from other providers 
Clients with complex needs require co-ordinated help from a broad range of services. 
Referrals to a wide variety of organisations should be possible, including: 
•	 housing 
•	 social support and ancillary services 
•	 benefit advice and legal advice 
•	 employment 
•	 leisure. 
The care co-ordinator should act as the central point of referral and information. 
Stigma and shame 
Stigma and consequent shame of mental illness can be a substantial problem for 
individuals, particularly those in prison. Shame brings with it the urge to ‘hide’; for 
many individuals the emotion may be so great that lashing out at others, or even 
death, seems the only escape. However, close observation may only serve to increase 
shame. Therefore institutions need to consider how to manage the balance between 
safety and exacerbation of problems. Also, for many individuals with a personality 
disorder, close proximity to other people can be both frightening and painful. Thus 
close observation and regular questioning (by well-meaning staff) can be distressing 
and could lead to an escalation of attempts to escape (through harm to self or 
aggression/violence). 
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Appendix A: Guidance on consent and 
confidentiality 
The sharing of confidential information 
The general principle for the sharing of information within the Integrated Drug 
Treatment System is that: 
“Any information required to provide adequate continuity of drug treatment should, 
with the client’s informed consent, be shared between CARATs and healthcare teams 
and with partner services such as Criminal Justice Integrated Teams, community drug 
treatment providers and Probation offender managers.” 
Integrated drug treatment in prisons plan 2009/10: Guidance notes
(National Treatment Agency for Substance Misuse 2008) 
It is essential that at each point of contact where information is to be shared between 
agencies/service providers, client confidentiality is observed. When consent is sought 
from a client, s/he must be informed about the uses to which the information will be 
put. Informed consent can be seen as having been gained when the client has been 
given sufficient and suitable information and is able to understand and assess the risks 
of participation. Substance dependence or the experience of withdrawal symptoms 
are not necessarily impediments to consent to share information, but the timing of 
a request for consent should be considered for newly arrived prisoners who display 
cognitive impairment that may be related to acute intoxication or withdrawal. 
Through the assessment process and use/completion of the Drug Interventions Record 
(DIR) as appropriate, CJIT workers will gain from clients prior to entry into custody 
written informed consent to share information from their assessment (to facilitate 
continuity of care) with the IDTS (CARATs/healthcare) team in prison. IDTS (healthcare 
and CARATs) teams will need to ensure that they, too, gain informed consent at the 
appropriate stages in their clients’ period of treatment. 
The legal contexts for both consent and confidentiality in relation to drug treatment in 
prison are set out below. 
Legal context: Consent to treatment 
The law presumes that an adult (a person aged 18 and over) has the capacity to take 
their own healthcare decisions unless the opposite is proved. It is important not to 
underestimate the capacity of a client with a learning disability to understand. Many 
people with learning disabilities have the capacity to consent if time is spent explaining 
the issue to the individual in simple language, using visual aids and signing if necessary. 
Further guidance on this is set out in the Department of Health’s booklet Seeking 
consent: working with people with learning disabilities (DH, 2001). 
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“Seeking consent should usually be seen as a process, not a one-off 
event. People who have given consent to a particular intervention are 
entitled to change their minds and withdraw their consent at any point if 
they still have the capacity (are ‘competent’) to do so. Similarly, they can 
change their minds and consent to an intervention that they have earlier 
refused. It is important to let each person know this, so that they feel able 
to tell you if they change their mind.” 
Seeking Consent: Working with People in Prison (DH, 2002) 
Legal context: Disclosure of information 
There is a range of statutory provisions that influence the way in which client 
information is used or disclosed. Details of these can be found on the Department 
of Health website at www.dh.gov.uk. 
The key principle of the common law of confidentiality is that information confided 
should not be used or disclosed further, except as originally understood by the confider, 
or with their subsequent permission. 
While judgements have established that confidentiality can be breached ‘in the 
public interest’, these have centred on case-by-case consideration of exceptional 
circumstances. 
Under common law, staff are permitted to disclose personal information (for instance, 
to a probation officer) in order to prevent and support detection, investigation and 
punishment of serious crime and/or to prevent abuse or serious harm to others where 
they judge, on a case-by-case basis, that the public good that would be achieved by 
the disclosure outweighs both the obligation of confidentiality to the individual client 
concerned and the broader public interest in the provision of a confidential service. 
Guidance for professionals on factors that may be considered in such judgements is 
provided by professional regulatory bodies such as the General Medical Council, the 
Nursing and Midwifery Council and the Royal Pharmaceutical Society of Great Britain 
(www.rpsgb.org/protectingthepublic/ethics/). 
The Data Protection Act 1998 imposes constraints on the processing of personal 
information in relation to living individuals. It identifies eight data protection principles 
that set out standards for information handling. In the context of confidentiality, the 
most significant are: 
•	 Principle 1, which requires processing to be fair and lawful and imposes 
other restrictions; 
•	 Principle 2, which requires personal data to be processed for one or more 
specified and lawful purposes; and 
•	 Principle 7, which requires personal data to be protected against
unauthorised or unlawful processing and against accidental loss, destruction
or damage. It also provides for an individual’s right of access to personal data. 
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Within the Human Rights Act 1998 there is a requirement that actions that interfere 
with the right to respect for private and family life (e.g. disclosing confidential 
information) must also be justified as being necessary to support legitimate aims and 
be proportionate to the need. 
Current understanding is that compliance with the Data Protection Act 1998 and the 
common law of confidentiality should satisfy human rights requirements (NHS Code 
of Practice: Confidentiality (DH, 2003), www.dh.gov.uk/en/Publicationsandstatistics/ 
Publications/PublicationsPolicyAndGuidance/DH_4069253). 
Where a client has been identified as at risk of self-harm/suicide, information that is 
relevant to ensure appropriate care and support must be shared with the ACCT Case 
Manager. Information on the client’s needs and proposed/existing drugs interventions 
should be provided at ACCT case reviews. 
As both healthcare and CARATs teams operate within the same legislative 
consent and confidentiality framework (i.e. the Data Protection Act 1998, 
the Human Rights Act 1998 and the common law of confidentiality), any 
information required to provide adequate drug treatment should, with the 
client’s informed consent, be shared between CARATs and healthcare teams. 
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